May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w
C-Path Appoints Quantitative Sciences Expert as New Sr. Vice President Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy devel
July 26, 2022 PSTC 15-year Anniversary Webinar Series Join scientists from PSTC member companies, health authorities and other key opinion leaders during the PSTC 15-year Anniversary W
C-Path Selects New Leaders of Data Science and Quantitative Medicine TUCSON, Ariz., April 26, 2021 — Critical Path Institute (C-Path) has named Amanda J. Borens, M.S., as Executive Director of Data
C-Path Opens Access to Duchenne Regulatory Science Consortium Database Database will allow sharing of individual-level data with the goal of accelerating therapy development for Duchenne muscular dystr
Data Collaboration Center Request for Proposal RFP: The RDCA Branding & Web Portal Data Collaboration Center’s (DCC’s) platform development team is seeking a proposal, i
May 19, 2021-May 20, 2021 View Now | 2021 PKD Regulatory Summit | May 19-20 The Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium (PKDOC), The PKD Foundation and Otsuka invite you vi
April 14, 2021-April 15, 2021 Identifying COAs for Use in Rare Disease Treatment Trials Presented at the PRO Consortium 2021 Workshop, held virtually April 14-15, 2021:
CPTA Welcomes Triplet Therapeutics Chief Medical Officer as Industry Co-Director C-Path’s Critical Path to Therapeutics for the Ataxias Consortium is pleased to announce the appointment of Irina Antonijevi
C-Path’s Alzheimer’s Disease Consortium Expands Data Repository New patient-level data will facilitate more efficient clinical trial design TUCSON, Ariz., April 12, 2021 — The Critical Path In